1. Introduction {#sec1}
===============

Synthesis and functionalization of porphyrins \[[@B1]\] have long been of great interest in the chemistry community because of the vast potentials and demands for porphyrin derivatives in diverse fields, such as materials \[[@B2], [@B3]\], supramolecular chemistry \[[@B4], [@B5]\], biomimetic models \[[@B6]\], catalysis \[[@B7], [@B8]\], photodynamic therapy \[[@B9]\], and ionophores \[[@B10]\]. Porphyrins were reported to exhibit a variety of biological activities. This is due to the fact that natural and synthetic porphyrins have relatively low toxicity *in vitro* and *in vivo* and they possess antitumor \[[@B11], [@B12]\] and antioxidant effects \[[@B13], [@B14]\] and have a good potential for metal ions complexation. The ability for numerous chemical modifications and the large number of different mechanisms by which porphyrins affect microbial and viral pathogens place porphyrins into a group of compounds with an outstanding potential for discovery of novel agents, procedures, and materials active against pathogenic microorganisms \[[@B15]\]. Metalloporphyrins are the basis of new antifungal, antiparasitic, and anticancer drugs because modification of the porphyrin periphery confers qualitatively a new spectrum of activities to metalloporphyrins \[[@B16], [@B17]\]. It has been reported that metal complexation alters the various physiological properties, especially the cytotoxic and antitumor activities, of many naturally occurring compounds. Zirconium(IV) porphyrins have gained attention from global researchers due to the peculiar characteristics of this class of compounds. To the best of our knowledge, the chemistry of zirconium(IV) porphyrinates remains underdeveloped, being limited to OEP and TPP, with a small variety of derivatives with different anions to balance the remaining +2 charge and ligands to satisfy the 7-8 coordination sphere. The metal ion in these complexes is oxophilic \[[@B18]\]; thus, it may show preference for carboxylate and other oxygen-bearing anionic ligands. A lot of work is reported on the spectral, electrochemical, and biological properties of zirconium and hafnium phthalocyanines with different outplaned organic ligands \[[@B19]--[@B22]\], but comparatively less work has been done on zirconium(IV) porphyrin complexes with carboxylate as axial ligand which are expected to be biomedically relevant complexes. Salicylic acid and its derivatives are biologically important molecules, and in view of the interesting results obtained from zirconium(IV) phthalocyanines with various out-of-plane ligands, it is considered worthwhile to make a study of axially substituted zirconium(IV) porphyrin with salicylic acid and its derivatives. We believe that these novel compounds will be fundamental substances for potential applications in the future. With this objective, we aimed at the synthesis, spectroscopic characterization, and biological studies on axially substituted zirconium(IV) porphyrins with salicylic acid and 5-sulfosalicylic acid as axial ligands.

2. Experimental {#sec2}
===============

2.1. Materials and Instruments {#sec2.1}
------------------------------

All the chemicals were of analytical grade and used as received unless otherwise noted. Pyrrole was distilled over potassium hydroxide pellets under vacuum prior to use. All the organic solvents that were used for the synthesis and for chromatographic separations were dried before use. (TBA)PF~6~ was recrystallized twice from EtOAc and dried in vacuo prior to use. Elementary analyses (C, H, N, and S) were obtained on a Vario EL III and CHNS-932 Leco Elemental Analyzer. UV-vis spectra were recorded on a T90+ UV/VIS spectrophotometer in the range 350--700 nm. The oscillator strength (*f*) of the transitions in absorption spectra were calculated from the expression $$\begin{matrix}
{f = {\,\,}4.33 \times 10^{- 9}{\varepsilon\Delta\nu}_{1/2},} \\
\end{matrix}$$ where *ε* is the molar absorption coefficient in dm^3^mol^−1^cm^−1^ and Δ*ν* ~1/2~ is the full width at half maximum in cm^−1^. Infrared spectra were recorded on a Perkin Elmer-spectrum 400 FTIR spectrophotometer using KBr pellets in the range of 4000--400 cm^−1^. The ^1^H NMR spectra were recorded on a Bruker Avance II 500 (500 MHz) using tetramethylsilane as internal standard and CDCl~3~ as solvent. TGA and DTA were recorded on Linseis STA PT-100 thermometer using around 21.87 mg of dry samples at the heating rate of 10°C/min in an air atmosphere. The cyclic voltammetry measurements were carried out by an Autolab computer-controlled electrochemical measurement system equipped with a potentiostat. A three-electrode system comprised a gold working electrode, a Pt wire counter electrode, and a saturated Ag/AgCl in KCl as reference electrode. A 0.1 M solution of n-tetrabutylammonium hexafluorophosphate, (TBA)PF~6~ in freshly distilled CH~2~Cl~2~, was used as a supporting electrolyte during the electrochemical experiments. The scan rate was 20 mV/s and the range was −0.2--0.2 mV. The concentration of the porphyrins was 10^−6 ^M. The solutions were purged with oxygen-free nitrogen gas prior to measurements, and all measurements were made at room temperature. Fluorescence measurements were performed on Synergy MX Biotek Multimode Reader. The porphyrins solution prepared in CH~2~Cl~2~ was 10^−6^ M.

2.2. Biological Studies {#sec2.2}
-----------------------

### 2.2.1. Antibacterial Studies {#sec2.2.1}

Qualitative analysis for screening of antibacterial activity was carried out by Agar well-diffusion method \[[@B23]\] with modifications. The compound was tested against two Gram positive bacteria (*Bacillus subtilis* MTCC2389 and *Staphylococcus aureus* MTCC7443) and three Gram negative bacteria (*Micrococcus luteus* MTCC4821, *Escherichia coli* MTCC2127, and *Pseudomonas fluorescens* MTCC4828). 20 mL of sterilized nutrient agar was inoculated with 100 mL of bacterial suspension (10^8^ CFU/mL) and then poured onto sterilized Petri plate. The agar plate was left to solidify at room temperature. A well of 6 mm was aseptically bored into the agar plate. Then, 20 mL of the complexes (diluted with DMSO, 1 : 1) was added in each well. Chloramphenicol (10 *μ*g) was used as a positive reference to determine the sensitivity of bacteria. The plates were kept at 4°C for 2 hours to allow the dispersal and then incubated at 37°C for 24 hours.

### 2.2.2. *In Vitro* Cytotoxicity against Human Cancer Cell Lines {#sec2.2.2}

*Cell Lines and Cell Cultures.* The human prostrate (PC-3), lung (A-549), and acute lymphoblastic leukemia (THP-1) cell lines were grown and maintained in RPMI-1640 medium, pH 7.4, whereas DMEM was used for breast (MCF-7). The media were supplemented with FCS (10%), penicillin (100 units/mL), streptomycin (100 *μ*g/mL), and glutamine (2 mM), and cells were grown in CO~2~ incubator (Heraeus, GmbH, Germany) at 37°C with 90% humidity and 5% CO~2~. Cells were treated with samples dissolved in DMSO while the untreated control cultures received only the vehicle (DMSO, \<0.2%).

*Cytotoxicity Assay. In vitro* cytotoxicity against human cancer cell lines was determined using sulforhodamine B dye assay \[[@B24], [@B25]\]. Both test samples stock solutions were prepared in DMSO.

2.3. Synthesis of Axially Ligated Zirconium(IV) Porphyrins Complexes {#sec2.3}
--------------------------------------------------------------------

### 2.3.1. Synthesis of Macrocycles {#sec2.3.1}

The metal free-base meso-tetraphenylporphyrin (TPP) and its parasubstituted derivative (RTPP, R = p-CH~3~, p-NO~2~, p-Cl) were synthesized by the direct condensation of pyrrole with substituted benzaldehydes according to the documented procedure \[[@B26]\]. The purified porphyrin complexes were obtained in yields of less than 25%.

### 2.3.2. Synthesis of Dichloro(5,10,15,20-tetraarylporphinato)zirconium(IV), Cl~2~Zr(RTPP) {#sec2.3.2}

Dichloro(5,10,15,20-tetraphenylporphinato)zirconium(IV), Cl~2~Zr(RTPP)s were obtained by the reaction of mesotetraphenylporphyrin and its parasubstituted derivatives, RTPP (R = p-H, p-CH~3~, p-NO~2~, p-Cl) with zirconium(IV)chloride by benzonitrile method \[[@B27]\]. RTPP (0.41 mmol) was boiled with ZrCl~4~ (2.64 mmol) in 15 mL of benzonitrile at reflux for 1--3 hours. The reaction course was monitored by absorption spectra of the reaction mixture. The refluxing was stopped when in the electron absorption spectra of the reaction mixture disappeared the absorption bands of RTPP. The complex was isolated in the solid form after distilling benzonitrile off in a vacuum. Then the saturated solution of the complex in chloroform was subjected to chromatography on basic Al~2~O~3~ using CHCl~3~ as eluent. After chromatography, the solution of the zirconium(IV) complex was treated additionally with gaseous HCl. The purified dichlorozirconium(IV) porphyrin complexes were obtained in yields of around 30%.

*(1) Dichloro(5,10,15,20-tetraphenylporphinato)zirconium(IV), Cl* ~2~ *ZrTPP.* Red-violet. Anal. Calcd. for C~44~H~28~Cl~2~N~4~Zr(%): C 68.20, H 3.64, N 7.23. Found: C 68.32, H 3.66, N 7.24. UV-vis spectra (CHCl~3~)*λ* ~max⁡~: 407 nm (Soret band), 541 nm (Q-band). IR (KBr)*ν* ~max⁡~: 485 cm^−1^ (*ν* ~Zr−N~). ^1^H NMR (500 MHz, CDCl~3~): 8.87 (8H, s, pyrrole), 8.32 (4H, d, o-phenyl), 8.04 (4H, d, o-phenyl), 7.64 (12H, s, m-phenyl, p-phenyl).

*(2) Dichloro(meso-tetra(p-methylphenyl)porphyrinato)zirconium(IV), Cl* ~2~ *Zr(p-CH* ~3~ *TPP).* Yellowish brown solid. Anal. Calcd. for C~48~H~36~Cl~2~N~4~Zr(%): C 69.38, H 4.37, N 6.74. Found: C 69.42, H 4.41, N 6.79. UV-vis spectra(CHCl~3~)*λ* ~max⁡~: 409 nm (Soret band), 540 nm (Q-band). IR (KBr)*ν* ~max⁡~: 508 cm^−1^ (*ν* ~Zr−N~). ^1^H NMR (500 MHz, CDCl~3~): 8.80 (8H, s, pyrrole), 8.28 (4H, s, o-phenyl), 8.00 (4H, s, o-phenyl), 7.65 (8H, s, m-phenyl), 2.70 (s, 12H, p-CH~3~).

*(3) Dichloro(meso-tetra(p-chlorophenyl)porphyrinato)zirconium(IV), Cl* ~2~ *Zr(p-ClTPP).* Red-violet solid. Anal. Calcd. for C~44~H~24~Cl~6~N~4~Zr(%): C 57.91, H 2.65, N 6.14. Found: C 58.03, H 2.68, N 6.23. UV-Vis spectra (CHCl~3~)*λ* ~max⁡~: 416 nm (Soret band), 541 nm (Q-band). IR (KBr)*ν* ~max⁡~: 485 cm^−1^ (*ν* ~Zr−N~). ^1^H NMR (500 MHz, CDCl~3~): 8.97 (8H, s, pyrrole), 8.33 (4H, d, o-phenyl), 8.13 (4H, s, o-phenyl), 7.59 (8H, s, m-phenyl).

*(4) Dichloro(meso-tetra(p-nitrophenyl)porphyrinato)zirconium(IV), Cl* ~2~ *Zr(p-NO* ~2~ *TPP).* Reddish brown solid. Anal. Calcd. for C~44~H~24~Cl~2~N~8~O~8~Zr(%): C 55.35, H 2.53, N 11.74. Found: C 55.42, H 2.56, N 11.63. UV-vis spectra (CHCl~3~)*λ* ~max⁡~: 414 nm (Soret band), 543 nm (Q-band). IR (KBr)*ν* ~max⁡~: 482 cm^−1^ (*ν* ~Zr−N~). ^1^H NMR (500 MHz, CDCl~3~): 9.05 (8H, s, pyrrole), 8.42 (4H, s, o-phenyl), 8.04(4H, s, o-phenyl), 7.65(8H, s, m-phenyl).

### 2.3.3. Synthesis of Axially Ligated Zr(IV) Porphyrins: SAZr(RTPP) and 5-SSAZr(RTPP) {#sec2.3.3}

Cl~2~Zr(RTPP) (0.15 mmol) in 25 mL CHCl~3~ was treated with excess of respective salicylate (sodium salicylate/sodium 5-sulfosalicylate) (0.56 mmol) in 25 mL CH~3~OH and stirred under reflux for 12 hours \[[@B28]\]. After concentration, the mixture was dissolved in minimum quantity of CH~2~Cl~2~ and extracted four times with distilled water to remove excess salicylic acid/5-sulfosalicylic acid. The lower layer containing compound in CH~2~Cl~2~ was collected, and then it was filtered through anhydrous Na~2~SO~4~ in order to remove water. The compound was recrystallized from dichloromethane-hexane solution (1 : 1). The same procedure was applied for the synthesis of all axially ligated zirconium porphyrin complexes as described above. The purified axially ligated zirconium porphyrin complexes were obtained in yields of 40--45%.

*(1) SAZrTPP.* Red solid. Anal. Calcd. for C~51~H~32~N~4~O~3~Zr(%): C 72.92, H 3.84, N 6.67. Found: C 72.92, H 3.76, N 6.63. UV-vis (CHCl~3~)*λ* ~max⁡~: 418 nm (Soret band), 549 nm, 590 nm (Q-band). ESI-MS (CH~3~OH:CH~3~CN): *m/z*calcd. for C~51~H~32~N~4~O~3~Zr: 840. Found 841 (\[M+H\]^+^); IR (KBr)*ν* ~max⁡~: 485 cm^−1^ (*ν* ~Zr−N~), 662 cm^−1^ (*ν* ~Zr−O~, phenolic SA), 719 cm^−1^ (*ν* ~Zr−O~, carboxylic SA). ^1^H NMR (500 MHz, CDCl~3~): *δ* (ppm) 8.93 (8H, s, pyrrole), 8.50 (4H, s, o-phenyl), 8.07 (4H, d, o-phenyl), 7.68 (12H, m, m-phenyl, p-phenyl), 6.98 (1H, q, 4-phenyl SA), 6.18 (4H, q, 5-phenyl SA), 6.16 (4H, d, 3-phenyl SA), 6.06 (1H, d, 6-phenyl SA).

*(2) 5-SSAZrTPP.* Dark reddish brown solid. Anal. Calcd. for C~51~H~32~N~4~O~6~SZr(%): C 66.57, H 3.51, N 6.09, S 3.48. Found: C 66.53, H 3.64, N 6.07, S 3.48; UV-vis (CHCl~3~)*λ* ~max⁡~: 420 nm (Soret band), 549 nm, 587 nm (Q-band). ESI-MS (CH~3~OH:CH~3~CN): *m/z*calcd. for C~51~H~32~N~4~O~6~SZr: 920; found 921 (\[M+H\]^+^). IR (KBr)*ν* ~max⁡~: 500 cm^−1^ (*ν* ~Zr−N~), 678 cm^−1^ (*ν* ~Zr−O~, phenolic 5-SSA), 722 cm^−1^ (*ν* ~Zr−O~, carboxylic 5-SSA). ^1^H NMR (500 MHz, CDCl~3~): *δ* (ppm) 8.96 (8H, s, pyrrole), 8.53 (4H, s, o-phenyl), 8.11 (4H, d, o-phenyl), 7.71 (12H, m, m-phenyl, p-phenyl), 7.10 (1H, q, 4-phenyl 5-SSA), 7.15 (1H, d, 3-phenyl 5-SSA), 7.19 (1H, s, 6-phenyl 5-SSA).

*(3) SAZr(p-CH* ~3~ *TPP).* Brown solid. Anal. Calcd. for C~55~H~40~N~4~O~3~Zr(%): C 73.71, H 4.50, N 6.25. Found: C 73.63, H 4.49, N 6.25; UV-vis (CHCl~3~)*λ* ~max⁡~: 422 nm (Soret band), 547 nm, 591 nm (Q-band). ESI-MS (CH~3~OH:CH~3~CN): *m/z*calcd. for C~55~H~40~N~4~O~3~Zr: 896. Found 897 (\[M+H\]^+^). IR (KBr)*ν* ~max⁡~: 510 cm^−1^ (*ν* ~Zr−N~), 683 cm^−1^ (*ν* ~Zr−O~, phenolic SA), 713 cm^−1^ (*ν* ~Zr−O~, carboxylic SA). ^1^H NMR (500 MHz, CDCl~3~): *δ* (ppm) 8.94 (8H, s, pyrrole), 8.42 (4H, s, o-phenyl), 8.15 (4H, d, o-phenyl), 7.71 (8H, m, m-phenyl), 2.83 (12H, s, p-CH~3~), 6.93 (1H, q, 4-phenyl SA), 6.22 (4H, q, 5-phenyl SA), 6.15 (4H, d, 3-phenyl SA), 6.04 (1H, d, 6-phenyl SA).

*(4) 5-SSAZr(p-CH* ~3~ *TPP).* Brown red solid. Anal. Calcd. for C~55~H~40~N~4~O~6~SZr(%): C 67.67, H 4.13, N 5.39, S 3.28. Found: C 68.14, H 4.21, N 5.56, S 3.88. UV-vis (CHCl~3~)*λ* ~max⁡~: 423 nm (Soret band), 551 nm, 593 nm (Q-band). ESI-MS (CH~3~OH:CH~3~CN): *m/z*calcd for C~55~H~40~N~4~O~6~SZr: 974. Found 975 (\[M+H\]^+^). IR (KBr)*ν* ~max⁡~: 517 cm^−1^ (*ν* ~Zr−N~), 685 cm^−1^ (*ν* ~Zr−O~, phenolic SA), 715 cm^−1^ (*ν* ~Zr−O~, carboxylic 5-SSA). ^1^H NMR (500 MHz, CDCl~3~): *δ*(ppm) 8.96 (8H, s, pyrrole), 8.47 (4H, s, o-phenyl), 8.18 (4H, s, o-phenyl), 7.78 (8H, m, m-phenyl), 2.85 (12H, s, p-CH~3~), 7.06 (1H, q, 4-phenyl 5-SSA), 7.08 (1H, d, 3-phenyl 5-SSA), 7.17 (1H, s, 6-phenyl 5-SSA).

*(5) SAZr(p-ClTPP).* Red solid. Anal. Calcd. for C~51~H~28~Cl~4~N~4~O~3~Zr(%): C 62.64, H 2.89, N 5.73. Found: C 60.12, H 2.84, N 10.97; UV-vis spectra (CHCl~3~)*λ* ~max⁡~: 421 nm (Soret band), 551 nm, 594 nm (Q-band). ESI-MS (CH~3~OH:CH~3~CN): *m/z*calcd for C~51~H~28~Cl~4~N~4~O~3~Zr: 978; found 979 (\[M+H\]^+^). IR (KBr)*ν* ~max⁡~: 488 cm^−1^ (*ν* ~Zr−N~), 658 cm^−1^ (*ν* ~Zr−O~, phenolic SA), 721 cm^−1^ (*ν* ~Zr−O~, carboxylic SA). ^1^H NMR (500 MHz, CDCl~3~): *δ* (ppm) 9.12 (8H, s, pyrrole), 8.42 (4H, d, o-phenyl), 8.17 (4H, m, o-phenyl), 8.02 (8H, m, m-phenyl), 6.98 (1H, q, 4-phenyl SA), 6.30 (1H, q, 5-phenyl SA), 6.26 (4H, d, 3-phenyl SA), 6.16 (1H, d, 6-phenyl SA).

*(6) 5-SSAZr(p-ClTPP).* Brown solid. Anal. Calcd. for C~51~H~28~Cl~4~N~4~O~6~SZr(%): C 57.90, H 2.67, N 5.30, S 3.03. Found: C 55.64, H 2.53, N 10.23, S 3.32. UV-vis (CHCl~3~)*λ* ~max⁡~: 421 nm (Soret band), 552 nm, 595 nm (Q-band). ESI-MS (CH~3~OH:CH~3~CN): *m/z*calcd. for C~51~H~28~Cl~4~N~4~O~6~SZr: 1057. Found 1058 (\[M+H\]^+^). IR (KBr)*ν* ~max⁡~: 492 cm^−1^ (*ν* ~Zr−N~), 660 cm^−1^ (*ν* ~Zr−O~, phenolic SA), 722 cm^−1^ (*ν* ~Zr−O~, carboxylic SA). ^1^H NMR (500 MHz, CDCl~3~): *δ* (ppm) 9.25 (8H, s, pyrrole), 8.46 (4H, s, o-phenyl), 8.23 (4H, s, o-phenyl), 8.09 (8H, s, m-phenyl), 7.09 (1H, q, 4-phenyl 5-SSA), 7.15 (1H, d, 3-phenyl 5-SSA), 7.20 (1H, s, 6-phenyl 5-SSA).

*(7) SAZr(p-NO* ~2~ *TPP).* Red solid. Anal. Calcd. for C~51~H~28~N~8~O~11~Zr(%): C 60.05, H 2.77, N 10.99. Found: C 68.73, H 4.22, N 5.79. UV-vis (CHCl~3~)*λ* ~max⁡~: 424 nm (Soret band), 548 nm, 594 nm (Q-band). ESI-MS (CH~3~OH:CH~3~CN): *m/z*calcd. for C~51~H~28~N~8~O~11~Zr: 1020; found 1021 (\[M+H\]^+^). IR (KBr)*ν* ~max⁡~: 483 cm^−1^ (*ν* ~Zr−N~), 654 cm^−1^ (*ν* ~Zr−O~, phenolic SA), 724 cm^−1^ (*ν* ~Zr−O~, carboxylic SA). ^1^H NMR (500 MHz, CDCl~3~): *δ*(ppm) 9.17 (8H, s, pyrrole), 8.42 (4H, d, o-phenyl), 8.07 (4H, d, o-phenyl), 7.64 (8H, s, m-phenyl), 7.05 (1H, q, 4-phenyl SA), 6.55 (1H, q, 5-phenyl SA), 6.50 (1H, d, 3-phenyl SA), 6.18 (1H, d, 6-phenyl SA).

*(8) 5-SSAZr(p-NO* ~2~ *TPP).* Red solid. Anal. Calcd. for C~51~H~28~N~8~SO~14~Zr(%): C 55.68, H 2.57, N 10.19, S 2.91. Found: C 63.89, H 3.86, N 5.45, S 3.21. UV-vis (CHCl~3~)*λ* ~max⁡~: 425 nm (Soret band), 550 nm, 594 nm (Q-band). ESI-MS (CH~3~OH:CH~3~CN): *m/z*calcd. for C~51~H~28~N~8~SO~14~Zr: 1100; found 1101 (\[M+H\]^+^). IR (KBr)*ν* ~max⁡~: 487 cm^−1^ (*ν* ~Zr−N~), 667 cm^−1^ (*ν* ~Zr−O~, phenolic SA), 728 cm^−1^ (*ν* ~Zr−O~, carboxylic SA). ^1^H NMR (500 MHz, CDCl~3~): *δ*(ppm) 9.26 (8H, s, pyrrole), 8.45 (4H, s, o-phenyl), 8.11 (4H, d, o-phenyl), 7.65 (8H, m, m-phenyl), 7.23 (1H, q, 4-phenyl 5-SSA), 7.78 (1H, d, 3-phenyl 5-SSA), 7.92 (1H, s, 6-phenyl 5-SSA).

3. Results and Discussion {#sec3}
=========================

3.1. Synthesis and Characterization {#sec3.1}
-----------------------------------

The general synthetic routes to peripherally tetrasubstituted tetraphenylporphyrin derivatives (RTPP), their corresponding metallated, and axially ligated zirconium(IV) porphyrins are shown in Schemes [1](#sch1){ref-type="fig"}, [2](#sch2){ref-type="fig"}, and [3](#sch3){ref-type="fig"}, respectively. All of these new zirconium(IV) porphyrins were purified by column chromatography with aluminum oxide as adsorbent and were characterized by spectral data (UV-visible spectroscopy, IR spectroscopy, ^1^H NMR spectroscopy, mass spectral data, and elemental analysis). The characterization data of the new compounds are consistent with the assigned formula. All the free base porphyrins, substituted tetraphenylporphyrin zirconium(IV) chlorides, and substituted tetraphenylporphyrin zirconium(IV) salicylates, are water insoluble.

### 3.1.1. Spectral Analysis of Cl~2~Zr(IV)RTPP and SA/5-SSAZr(IV)RTPP {#sec3.1.1}

The structures of all free base porphyrins (RTPP), substituted tetraphenylporphyrin zirconium(IV) chlorides Cl~2~Zr(IV)RTPP and substituted tetraphenylporphyrin zirconium(IV) salicylates (SA/5-SSAZr(IV)RTPP), are characterized by UV-vis, and the spectral data are listed in Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}. The UV-vis data shows that many of the absorption bands of the parasubstituted derivatives exhibit small shifts to longer wavelength, that is, bathochromic shift (red shift) as compared to the spectrum of TPP. The most pronounced bathochromic shift occurs in p-NO~2~TPP with paranitro group on mesophenyl ring of the porphyrin but in all the substituted tetraphenylporphyrin, intensities of all the peaks are higher than those of the parent tetraphenylporphyrin. The reason might be that the strong electron-withdrawing-NO~2~ group decreased the electronic density of the porphyrin ring. Thus, the *π*-*π*\* electron excitation of the porphyrin ring required absorbing the light of smaller energy (longer wavelength).

By comparing the UV-vis data in [Table 1](#tab1){ref-type="table"}, it was noticed that in the visible absorption spectra, free base porphyrins show an intense absorption, referred to as the Soret band at around 400 nm and four weaker absorptions known as Q bands between 450 nm and 800 nm. When the metal ion was inserted into the porphyrin ring, the number and intensity of the Q bands were found to decrease and the B (Soret) band showed a slight blue shift ([Figure 1](#fig1){ref-type="fig"}). The reason might be that the structural symmetry of zirconium(IV) porphyrin compounds was improved and the energy gap decreased as compared to the free base porphyrins \[[@B29]\]. In axially ligated zirconium(IV) porphyrin complexes, both B- and Q-bands regions of the spectra show slight red shift. The red shift may be due to structural distortion in the porphyrin macrocycle and concomitant electronic coupling of the metalloporphyrin to the salicylate mediated by the zirconium metal ion \[[@B18]\]. The optical absorption spectra of the compounds of the axially ligated zirconium(IV) porphyrins were when recorded in different solvents; only marginal changes of *λ* ~max⁡~ values, absorption coefficient (*ε*), and oscillatory strength (*f*) were observed. It is found that with the increase in polarity of the solvents, B- and Q-bands in axially ligated Zr(IV) metal derivatives with different porphyrins show a slight red shift with progressive broadening of bands indicating that the magnitude of red shift of B- and Q-bands depends on the nature of the solvent used. This is so since excited state is more polar than the ground state and hence stabilization is greater relative to the ground state in polar solvents. It is observed that for all the axially ligated Zr(IV) derivatives, B- and Q-bands exhibit a red shift on increasing the polarity of the solvents in the order: acetone \> chloroform \> toluene ([Figure 2](#fig2){ref-type="fig"}). The magnitude of change of the "*f*" values in axially ligated Zr(IV) metal derivatives of porphyrins reveal the relative strength of interaction.

Infrared spectral data of above porphyrin compounds is listed in [Table 3](#tab3){ref-type="table"}. It is found that the *ν*(N--H) stretching and bending frequencies of free base porphyrins are located at \~3400--3320 cm^−1^ and \~960 cm^−1^, respectively \[[@B30]\]. When the zirconium ion was inserted into the porphyrin ring, the N--H vibration frequency of free base porphyrins disappeared and the characteristic *ν*(Zr--N) vibration frequency was found at \~500--400 cm^−1^, which indicated the formation of zirconium(IV) porphyrin compounds \[[@B31]\]. In the spectra of all the axially ligated zirconium(IV) porphyrin complexes, the band due to *ν*(O--H) of the ligand disappeared indicating the coordination of phenolic oxygen to the metal via deprotonation \[[@B32]\]. The band assigned to the *ν*(C--O) stretching show upward shift in the range \~1264--1249 cm^−1^, which is due to the coordination of the phenolic oxygen to Zr(IV) porphyrins \[[@B33]\]. The incorporation of salicylates in Zr(IV) metal derivatives of different porphyrins, that is, SA/5-SSAZrRTPP, is further confirmed by the appearance of Zr--O vibrational frequencies in the range 690--662 cm^−1^ and 740--719 cm^−1^ corresponding to the ligation of zirconium to oxygen of phenolic and carboxylic groups of salicylate, respectively. Thus, the zirconium atom in the centre of porphyrin ring coordinates with the salicylate group axially to form six-coordinate complex of Zr(IV) porphyrin.

^1^H NMR data of free base porphyrin, their corresponding metallated, and axially ligated zirconium(IV) porphyrin complexes in CDCl~3~ at 298 K is listed [Table 4](#tab4){ref-type="table"}. In all the metallated porphyrins, there was absence of signal related to N--H protons and shift in other signals indicating the insertion of zirconium in porphyrin macrocycle \[[@B31]\]. Generally, the presence of Zr(IV) metal in the porphyrin ring shifts the resonances of the porphyrin\'s protons to downfield accompanied by marginal changes in the pattern. One of the important features of axially ligated Zr(IV) derivatives of porphyrins is that the metal is almost out of the plane of the porphyrin ring which has earlier been reviewed in the literature, responsible for the production of asymmetric environment above and below the plane of the macrocycle which ultimately accounts for the pronounced nonequivalence of the orthoprotons of the phenyl rings. In axially ligated zirconium(IV) porphyrin complexes, the signals of axial salicylic and 5-sulfosalicylic fragment protons are shifted to higher field in comparison to the signals of porphyrin protons and also in comparison to proton signals of free salicylic and 5-sulfosalicylic acids respectively \[[@B34]\]. These positions of protons show that axial ligand is under the influence of *π*-conjugated system of porphyrin macrocycle \[[@B22]\]. This is most probably due to deshielding effect resulting from the **σ**-donation of electron density upon bond formation as compared to the shielding effect of the porphyrin.

Mass spectrometric characterization of SA/5-SSAZrRTPP complexes employed ESI as soft ionization technique. The mass spectra of axial ligated zirconium(IV) porphyrins with salicylic acid/5-sulfosalicylic acid are characterized by the presence of the molecular ion peak for monomeric form followed by a degree of fragmentation when employing this technique, which suggested that axial ligand was labile. The substituents such as sulphonates in the axial ligand were labile too. The major losses are 81, 104, and 33 corresponding to the loss of SO~3~H group, salicylic fragment, and H~2~O molecules. The obtained ESI-MS data display that the molecule of axially ligated zirconium(IV) porphyrins contain one or two molecules of solvent coordinated to the central zirconium atom, which are not labile sufficiently and present in all molecular ions. This fact can be explained by the coordinated unsaturation of zirconium atom \[[@B22]\].

In the present investigation, the variations of emission properties in free base porphyrin p-CH~3~TPP and its corresponding metallated and axially ligated Zr(IV) porphyrins have been studied ([Table 5](#tab5){ref-type="table"}). The freebase porphyrins exhibit two emission bands at 653 and 715 nm corresponding to Q(0,0) and Q(0,1) transitions, respectively, the intensity of the Q(0,0) being higher than the Q(0,1) transition. The complexes Cl~2~Zr(p-CH~3~TPP), SAZr(p-CH~3~TPP), and 5-SSAZr(p-CH~3~TPP) are emissive and show intraligand fluorescence comparable to other regular metalloporphyrins with maxima occurring at 653, 660, and 657 nm, respectively. However, the emission bands of axially ligated Zr(IV) porphyrins are blue shifted compared to free base porphyrins. This behavior is attributed to an enhanced spin-orbit coupling induced by the presence of the heavy-atom central metals in zirconium(IV) porphyrins complexes, which leads to a more efficient intersystem crossing from the lowest porphyrin singlet excited state ^1^S~1~(*π*, *π*\*) to the corresponding triplet manifold and thus reduces the probability of fluorescent emission \[[@B35]\]. Thus, the excitation spectrum of fluorescence is in agreement with absorption spectrum ([Figure 3](#fig3){ref-type="fig"}).

Cyclic voltammetric studies have been carried out for Cl~2~Zr(p-CH~3~TPP) and its salicylate and 5-sulfosalicylate ligated Zr(IV) derivatives to elucidate the effects of the peripheral substituents on the electrochemical redox potentials ([Table 6](#tab6){ref-type="table"}). The electrochemical redox processes of the porphyrin and their metallated derivatives arise primarily from the *π* electron system of the macrocycle. [Figure 4](#fig4){ref-type="fig"} shows the cyclic voltammogram of Cl~2~Zr(p-CH~3~TPP) in CH~2~Cl~2~. In the oxidative scan, two redox couples were observed at 0.66 and 1.22 V corresponding to the formation of porphyrin cation radical and porphyrin dication, respectively. There is a wave in the reductive scan at 1.30 V. The wave is characteristic of one electron reduction of the macrocycle. The data clearly demonstrated the formation of the porphyrin radical anion and inability to reduce Zr(IV) metal centre \[[@B36]\].

For the investigated salicylate ligated zirconium(IV) porphyrins, we observed one reversible reduction wave and two reversible oxidation waves. The three waves for the complexes ([Table 6](#tab6){ref-type="table"}) can be attributed to one-electron processes ZrT(p-CH~3~)PPX^0/−1^, ZrT(p-CH~3~)PPX^1+/0^, and ZrT(p-CH~3~)PPX^2+/+1^ (X = SA, 5-SA), respectively, corresponding to the one-electron oxidation/reduction processes involving not only the porphyrin ring but also the entire system as a whole, including even the conjugated salicylate/5-sulfosalicylate ligand \[[@B37]\].

The central metal atom (zirconium), being electrochemically passive \[[@B38]\], plays the role of a "linkage" connecting the-conjugated systems into a whole integral. The zirconium(IV) porphyrin HOMO-LUMO gap can be expressed as Δ*E*, the potential difference between the first oxidation and the first reduction. The differences between the potentials of the first oxidation wave and the first reduction wave (*E* ~ox1~ − *E* ~red1~) are 1.93 V and 1.98 V for SAZr(p-CH~3~TPP) and 5-SSAZr(p-CH~3~TPP), respectively, allow us to assign these waves to oxidation/reduction processes involving the macrocyclic ring. The experimental Δ*E* values of substituted zirconium(IV) porphyrins are in the range of 1.88--1.98 V.

Thermal analysis of SAZrTPP is shown in [Figure 5](#fig5){ref-type="fig"}. The TG curve of SAZrTPP ([Figure 5](#fig5){ref-type="fig"}) shows a continuous weight loss starting from 150°C to 700°C, when a stable oxide of ZrO~2~ is formed. The initial weight loss of about 16.37% observed between 140°C and 175.8°C is attributed to the loss of salicylate group (the theoretical value = 16.32%). In the range of 200 to 280.2°C, up to 52.58% of the mass had been lost due to the loss of tetraphenyl groups (the theoretical value = 53.04%). At 426.1°C, up to 70.41% (the theoretical value = 69.01%) of the total mass had been lost which is attributed to the collapse of macrocyclic ligand; correspondingly, there is a large exothermic peak in DTA curve. The organic moiety decomposes further with increasing temperature. Further in the range 425--526.2°C, the weight loss reaches up to 80.47% which is attributed to the removal of pyrrole fragments. At 675.3°C the evident weight loss of 85.04% is due to the complete decomposition of SAZrTPP leaving behind stable zirconium oxide (the theoretical value = 85.33%). Simultaneously, there are some exothermal peaks in the range of 340--530°C on the DTA curve showing major weight loss in the region. The small exothermic peaks correspond to the loss of chains of the porphyrin ring and the large exothermic peak corresponds to the collapse of the porphyrin skeleton. The thermogravimetric analysis of the complex showed that zirconium(IV) porphyrin complex is stable up to approximately 150°C.

### 3.1.2. Biological Studies {#sec3.1.2}

The ability of porphyrins to accumulate in malignant tumors has led to the application of these compounds in diagnosis and treatment of these malignant neoplasms. In the present research work, some complexes were evaluated for antibacterial and anticancer activity. Antibacterial activity of the synthesized zirconium(IV) porphyrin complexes was tested by Agar well-diffusion method ([Table 7](#tab7){ref-type="table"}). The free base porphyrin and their corresponding metallated and axially ligated zirconium(IV) porphyrin complexes, namely, TPP, p-CH~3~TPP, p-NO~2~TPP, Cl~2~ZrTPP, Cl~2~Zr(p-CH~3~TPP), Cl~2~Zr(p-NO~2~TPP), SAZrTPP, 5-SSAZrTPP, SAZr(p-CH~3~TPP), 5-SSAZr(p-CH~3~TPP), SAZr(p-NO~2~TPP), and 5-SSAZr(p-NO~2~TPP) were tested at the concentration of 100 *μ*g/mL against five bacterial strains, namely, *Bacillus subtilis, Micrococcus luteus, Staphylococcus aureus, Pseudomonas fluorescens,*and*Escherichia coli.* Our results demonstrated antibacterial activity against most of the zirconium(IV) porphyrin complexes. Among all the complexes prepared, 5-SSAZr(p-NO~2~TPP) was found to be highly potential against all the five bacterial strains with sensitivity ranging from 10 to 15 mm zone of inhibition at 100 *μ*g/mL, respectively ([Table 7](#tab7){ref-type="table"}). SAZr(p-CH~3~TPP) complex showed sensitivity only against *B. subtilis*and *M. luteus* with zones of inhibition of 6 and 7 mm, respectively, and it was the only other complex after 5-SSAZr(p-NO~2~TPP) complex that showed antibacterial sensitivity against gram positive bacteria (*B. subtilis*). Other complexes, namely, Cl~2~ZrTPP, SAZrTPP, p-CH~3~TPP, Cl~2~Zr(p-CH~3~TPP), and 5-SSAZr(p-CH~3~TPP) showed sensitivity only against gram negative bacteria *E. coli* with zones of inhibition ranging from 6 to 14 mm, respectively. The rest of the complexes did not show any sensitivity against any bacterial strain used in the studies ([Table 7](#tab7){ref-type="table"}).

### 3.1.3. *In Vitro* Cytotoxicity {#sec3.1.3}

The cytotoxicity of SAZr(p-CH~3~TPP) and 5-SSAZr(p-CH~3~TPP) was evaluated against four human cancer cell lines, namely, breast (MCF-7), leukemia (THP-1), prostate (PC-3), and lung (A549) at different concentrations as shown in [Figure 6](#fig6){ref-type="fig"}. It was observed that both compounds showed less than 50% growth inhibition.

4. Conclusion {#sec4}
=============

In this paper, we have described the synthesis of pure porphyrins and their subsequent reactions with ZrCl~4~ and salicylic acid/5-sulfosalicylic acid so as to get their axially ligated Zr(IV) porphyrins. The structures of above porphyrin compounds were characterized by UV-vis, IR, ^1^H NMR, and elemental analysis. In axially ligated zirconium(IV) porphyrin complexes, bands showed slight red shift corresponding to the structural distortion in the porphyrin macrocycle and concomitant electronic coupling of the metalloporphyrin to the salicylate mediated by the zirconium metal ion. The infrared spectra of these compounds showed that salicylate groups axially ligated to zirconium(IV) porphyrins to form six-coordinate complexes of Zr(IV) porphyrins ([Figure 7](#fig7){ref-type="fig"}). Additionally, the ^1^H NMR spectral study of these compounds showed that signals of axial salicylic and 5-sulfosalicylic fragment protons are shifted to higher field in comparison to the signals of porphyrin protons and also in comparison to proton signals of free salicylic and/or 5-sulfosalicylic acids respectively. The ESI mass spectroscopy provided the information regarding the appearance of the molecular ion peak (*m*/*z*) and specific fragmentation. Meanwhile, cyclic voltammograms of axially ligated zirconium(IV) porphyrins complexes have shown three waves for the studied complexes which can be attributed to one-electron processes M(4-CH~3~TPP)X^0/−1^, M(4-CH~3~TPP)X^1+/0^, and M(4-CH~3~TPP)X^2+/+1^(X = SA, 5-SA; M = Zr). All these complexes exhibit reversible oxidation and reduction potentials characteristic of the porphyrin. The data of thermogravimetric analysis indicated that the zirconium(IV) porphyrins complexes are stable up to approximately 150°C. Their possible biological activities were also investigated and most of the samples exhibited moderate antimicrobial activity against test microorganisms. The two complexes screening for anticancer activity showed less than 50% growth inhibition.

![UV-Vis overlapped (a) B bands (b) Q bands of TPP and (Cl)~2~ZrTPP in chloroform.](BCA2013-903616.001){#fig1}

![UV-vis spectra of SAZrTPP (a) B bands (b) Q bands in different solvents.](BCA2013-903616.002){#fig2}

![S~1~ → S~0~ fluorescence spectrum of (a) SAZr(p-CH~3~TPP) and (b) 5-SSAZr(p-CH~3~TPP) in DMSO (C = 10^−6^ mol L^−1^, *λ* ~exc~ = 420 nm).](BCA2013-903616.003){#fig3}

![Cyclic voltammogram of Zr(p-CH~3~TPP) in CH~2~Cl~2~ containing 0.1 M (TBA)PF~6~. Scan rate 20 mV/s.](BCA2013-903616.004){#fig4}

![TGA (black line) and DTA (yellow line) picture of SAZrTPP.](BCA2013-903616.005){#fig5}

![Cytotoxicity of SAZr(p-CH~3~TPP) and 5-SSAZr(p-CH~3~TPP), where 2a = p-CH~3~TPP.](BCA2013-903616.006){#fig6}

![Proposed structure for axially ligated zirconium(IV) porphyrin complexes.](BCA2013-903616.007){#fig7}

![General synthetic route for the synthesis of tetraphenylporphyrin and its parasubstituted derivatives.](BCA2013-903616.sch.001){#sch1}

![General synthetic route for the synthesis of dichloro(tetraarylporphinato)zirconium(IV).](BCA2013-903616.sch.002){#sch2}

![General synthetic route for the synthesis of axially ligated Zr(IV) porphyrins complexes.](BCA2013-903616.sch.003){#sch3}

###### 

UV-vis data of free base porphyrins and corresponding tetraphenylporphyrin zirconium(IV) chlorides complexes in chloroform.

  No.   Compound              *λ* ~max⁡~ (nm)   
  ----- --------------------- ----------------- --------------------
  1     TPP                   418               515, 552, 590, 646
  2     p-CH~3~TPP            419               517, 552, 592, 646
  3     p-ClTPP               422               519, 555, 590, 655
  4     p-NO~2~TPP            423               516, 552, 592, 648
  5     Cl~2~ZrTPP            407               541
  6     Cl~2~Zr(p-CH~3~TPP)   409               540
  7     Cl~2~Zr(p-ClPP)       416               540
  8     Cl~2~Zr(p-NO~2~TPP)   416               542

###### 

UV-vis data of salicylate/5-sulfosalicylate ligated zirconium(IV) complexes in different solvents.

  Complex               Solvent        *λ* ~max⁡~, nm (log *ε*, M^−1^ cm^−1^)   *ν* ~1/2~ (cm^−1^)   *f*                           
  --------------------- -------------- ---------------------------------------- -------------------- ------------- ------- ------- -------
  SAZrTPP               Acetone        420 (4.8691)                             549 (3.544)          586 (2.278)   1123    792.3   0.351
  Chloroform            418 (4.7862)   549 (3.362)                              590 (2.398)          1134          796.6   0.307   
  Toluene               417 (4.7686)   547 (3.255)                              585 (2.176)          1151          808.4   0.292   
                                                                                                                                   
  5-SSAZrTPP            Acetone        422 (4.8651)                             550 (3.579)          590 (2.954)   1120    796.6   0.352
  Chloroform            420 (4.8463)   549 (3.414)                              587 (2.903)          1123          794.9   0.340   
  Toluene               417 (4.8331)   545 (3.301)                              585 (2.778)          1135          802.5   0.335   
                                                                                                                                   
  SAZr(p-CH~3~TPP)      Acetone        424 (4.8847)                             548 (3.362)          593 (2.994)   1110    799.6   0.368
  Chloroform            422 (4.8691)   547 (3.278)                              591 (2.972)          1123          800.8   0.350   
  Toluene               419 (4.8475)   547 (3.230)                              589 (2.968)          1138          802.2   0.347   
                                                                                                                                   
  5-SSAZr(p-CH~3~TPP)   Acetone        425 (4.8948)                             553 (3.672)          594 (3.064)   1106    785.2   0.370
  Chloroform            423 (4.8615)   551 (3.362)                              593 (3.334)          1118          789.3   0.353   
  Toluene               418 (4.8518)   547 (3.447)                              590 (3.230)          1143          802.5   0.351   
                                                                                                                                   
  SAZr(p-ClTPP)         Acetone        423 (4.8651)                             553 (3.518)          596 (2.976)   1151    785.1   0.365
  Chloroform            421 (4.8312)   551 (3.322)                              594 (2.970)          1127          788.3   0.331   
  Toluene               419 (4.7951)   551 (3.114)                              590 (2.930)          1134          790.7   0.304   
                                                                                                                                   
  5-SSAZr(p-ClTPP)      Acetone        424 (4.8759)                             552 (3.518)          597 (3.079)   1103    787.7   0.357
  Chloroform            421 (4.8318)   552 (3.342)                              595 (2.973)          1126          793.8   0.331   
  Toluene               421 (4.7951)   549 (3.176)                              590 (2.942)          1129          796.7   0.305   
                                                                                                                                   
  SAZr(p-NO~2~TPP)      Acetone        424 (4.9647)                             551 (3.5051)         596 (3.041)   1110    790.0   0.328
  Chloroform            424 (4.7331)   548 (3.397)                              594 (2.984)          1125          798.7   0.292   
  Toluene               422 (4.6599)   547 (3.230)                              593 (2.943)          1129          799.6   0.291   
                                                                                                                                   
  5-SSAZr(p-NO~2~TPP)   Acetone        423 (4.9498)                             547 (3.447)          598 (3.149)   1106    787.6   0.330
  Chloroform            425 (4.7259)   550 (3.362)                              594 (3.124)          1120          793.3   0.306   
  Toluene               422 (4.6541)   547 (3.204)                              594 (3.082)          1128          802.1   0.267   

###### 

Main infrared absorption frequencies of free base porphyrins, their corresponding metallated, and axially ligated Zr(IV) porphyrin complexes.

  Compound              IR (cm^−1^)                                                                    
  --------------------- ------------- ------ ----- ----- ------ ------ ----- ------------ ------ ----- ------
  TPP                   3326          2963   ---   797   1349   ---    ---   ---          ---    ---   ---
  Cl~2~ZrTPP            ---           2960   ---   800   1351   ---    485   ---          ---    ---   ---
  SAZrTPP               ---           2961   662   800   1328   1731   485   ---          1260   719   1379
  5-SSAZrTPP            ---           2960   678   801   1336   1730   500   1156, 1074   1264   722   1378
  p-CH~3~TPP            3416          2964   ---   794   1350   ---    ---   ---          ---    ---   ---
  Cl~2~Zr(p-CH~3~TPP)   ---           2955   ---   800   1339   ---    508   ---          ---    ---   ---
  SAZr(p-CH~3~TPP)      ---           2956   683   800   1335   1735   510   ---          1260   713   1377
  5-SSAZr(p-CH~3~TPP)   ---           2954   685   803   1329   1729   517   1172, 1119   1261   715   1379
  p-ClTPP               3428          2964   ---   797   1354   ---    ---   ---          ---    ---   ---
  Cl~2~Zr(p-ClTPP)      ---           2962   ---   803   1338   ---    485   ---          ---    ---   ---
  SAZr(p-ClTPP)         ---           2961   658   801   1328   1729   488   ---          1258   721   1377
  5-SSAZr(p-ClTPP)      ---           2961   660   802   1336   1726   492   1181, 1124   1260   722   1378
  p-NO~2~TPP            3449          2964   ---   800   1329   ---    ---   ---          ---    ---   ---
  Cl~2~Zr(p-NO~2~TPP)   ---           2952   ---   802   1332   ---    482   ---          ---    ---   ---
  SAZr(p-NO~2~TPP)      ---           2945   654   800   1335   1728   483   ---          1259   724   1375
  5-SSAZr(p-NO~2~TPP)   ---           2938   667   806   1337   1725   487   1174, 1124   1261   728   1378

###### 

^1^H NMR data of free base porphyrin and their zirconium(IV) porphyrins complexes in CDCl~3~at 298 K.

  ---------------------------------------------------------------------------------------------------------------------------
  Compound              Porphyrin\'s *δ*, ppm   Salicylate protons *δ*, ppm                             
  --------------------- ----------------------- ----------------------------- ------------------------- ---------------------
  TPP                   −2.76 (s, 2H)           8.82 (s, 8H)                  8.27 (s, 8H, H~o~)\       ---
                                                                              7.60 (s, 12H, H~m,p~)     

                                                                                                        

  Cl~2~ZrTPP                                    8.87 (s, 8H)                  8.32 (d, 4H, H~o~)\       ---
                                                                              8.04 (d, 4H, H~o~)\       
                                                                              7.64 (s, 12H, H~m,p~)     

                                                                                                        

  SAZrTPP                                       8.93 (s, 8H)                  8.50 (s, 4H, H~o~)\       6.06 (d, H~6~)\
                                                                              8.07 (d, 4H, H~o~)\       6.18 (q, H~5~)\
                                                                              7.68 (m, 12H, H~m,p~)     6.98 (q, H~4~)\
                                                                                                        6.16 (m, H~3~)

                                                                                                        

  5-SSAZrTPP                                    8.96 (s, 8H)                  8.53 (s, 4H, H~o~)\       7.19 (s, 1H, H~6~)\
                                                                              8.11 (s, 4H, H~o~)\       7.15 (d, 1H, H~3~)\
                                                                              7.71 (m, 12H, H~m,p~)     7.10 (q, 1H, H~4~)

                                                                                                        

  p-CH~3~TPP            −2.75 (s, 2H)           8.78 (s, 8H)                  8.18 (s, 8H, H~o~)\       ---
                                                                              7.56 (s, 8H, H~m~)\       
                                                                              2.64 (s, 12H, H~CH3~)     

                                                                                                        

  Cl~2~Zr(p-CH~3~TPP)                           8.80 (s, 8H)                  8.28 (d, 4H, H~o~)\       ---
                                                                              8.00 (s, 4H, H~o~)\       
                                                                              7.65 (s, 8H, H~m~)\       
                                                                              2.70 (s, 12H, H~CH3~)     

                                                                                                        

  SAZr(p-CH~3~TPP)                              8.94 (s, 8H)                  8.42 (d, 4H, H~o~)\       6.04 (d, H~6~)\
                                                                              8.15 (m, 4H, H~o~)\       6.22 (q, H~5~)\
                                                                              7.71 (m, 8H, H~m~)\       6.93 (q, H~4~)\
                                                                              2.83 (s, 12H, H~CH~3~~)   6.15 (d, H~3~)

                                                                                                        

  5-SSAZr(p-CH~3~TPP)                           8.96 (s, 8H)                  8.47 (s, 4H, H~o~)\       7.17 (s, 1H, H~6~)\
                                                                              8.18 (s, 4H, H~o~)\       7.08 (d, 1H, H~3~)\
                                                                              7.78 (m, 8H, H~m~)\       7.06 (q, 1H, H~4~)
                                                                              2.85 (s, 12H, H~CH~3~~)   

                                                                                                        

  p-ClTPP               −2.75 (s, 2H)           8.73 (s, 8H)                  8.25 (s, 4H, H~o~)\       ---
                                                                              7.75 (s, 4H, H~p~)        

                                                                                                        

  Cl~2~Zr(p-ClTPP)                              8.97 (s, 8H)                  8.33 (d, 4H, H~o~)\       ---
                                                                              8.13 (s, 4H, H~o~)\       
                                                                              7.59 (s, 8H, H~m~)        

                                                                                                        

  SAZr(p-ClTPP)                                 9.12 (s, 8H)                  8.42 (d, 4H, H~o~)\       6.16 (d, H~6~)\
                                                                              8.17 (m, 4H, H~o~)\       6.30 (q, H~5~)\
                                                                              8.02 (m, 8H, H~m~)        6.98 (q, H~4~)\
                                                                                                        6.26 (d, H~3~)

                                                                                                        

  5-SSAZr(p-ClTPP)                              9.25 (s, 8H)                  8.46 (s, 4H, H~o~)\       7.20 (s, 1H, H~6~)\
                                                                              8.23 (s, 4H, H~o~)\       7.15 (d, 1H, H~3~)\
                                                                              8.09 (s, 8H, H~m~)        7.09 (q, 1H, H~4~)

                                                                                                        

  p-NO~2~TPP            −2.84 (s, 2H)           8.83 (s, 8H)                  8.68 (s, 8H, H~o~)\       ---
                                                                              8.41 (s, 8H, H~m~)        

                                                                                                        

  Cl~2~Zr(p-NO~2~TPP)                           9.05 (s, 8H)                  8.42 (d, 4H, H~o~)\       ---
                                                                              8.04 (d, 4H, H~o~)\       
                                                                              7.79 (s, 8H, H~m~)        

                                                                                                        

  SAZr(p-NO~2~TPP)                              9.17 (s, 8H)                  8.42 (s, 4H, H~o~)\       6.18 (d, H~6~)\
                                                                              8.07 (d, 4H, H~o~)\       6.55 (q, H~5~)\
                                                                              7.64 (s, 8H, H~m~)        7.05 (q, H~4~)\
                                                                                                        6.52 (d, H~3~)

                                                                                                        

  5-SSAZr(p-NO~2~TPP)                           9.26 (s, 8H)                  8.45 (s, 4H, H~o~)\       7.92 (s, 1H, H~6~)\
                                                                              8.11 (s, 4H, H~o~)\       7.78 (d, 1H, H~3~)\
                                                                              7.65 (s, 8H, H~m~)        7.23 (q, 1H, H~4~)
  ---------------------------------------------------------------------------------------------------------------------------

###### 

Summary of the fluorescence band maxima at 23 K in DMSO.

  Compound              *λ* ~max⁡~, nm         
  --------------------- ---------------- ----- -----
  p-CH~3~TPP            450              653   715
  Cl~2~Zr(p-CH~3~TPP)   441              ---   653
  SAZr(p-CH~3~TPP)      440              609   660
  5-SSAZr(p-CH~3~TPP)   440              608   657

###### 

Electrochemical data for synthesized Cl~2~Zr(p-CH~3~TPP), SAZr(p-CH~3~TPP), and 5-SSAZr(p-CH~3~TPP) complexes in dichloromethane.

  Species               *E* ~OX2~/V   *E* ~OX1~/V   *E* ~red1~/V   Δ*E* d/V
  --------------------- ------------- ------------- -------------- ----------
  Cl~2~Zr(4-CH~3~TPP)   1.22          0.66          1.30           1.88
  SAZr(4-CH~3~TPP)      1.25          0.68          1.22           1.93
  5-SSAZr(4-CH~3~TPP)   1.28          0.70          1.15           1.98

###### 

*In vitro* antibacterial evaluation of free base porphyrin and the corresponding zirconium(IV) porphyrin complexes.

  Porphyrin (100 *µ*g/mL)             *B. subtilis*   *S. aureus*   *M. luteus*   *E. coli*   *P. fluorescens*
  ----------------------------------- --------------- ------------- ------------- ----------- ------------------
  TPP                                 ---             ---           ---           ---         ---
  Cl~2~ZrTPP                          ---             ---           ---           7           ---
  SAZrTPP                             ---             ---           ---           14          ---
  5-SSAZrTPP                          ---             ---           ---           ---         ---
  p-CH~3~TPP                          ---             ---           ---           6           ---
  Cl~2~Zr(p-CH~3~TPP)                 ---             ---           ---           11          ---
  SAZr(p-CH~3~TPP)                    6               ---           7             ---         ---
  5-SSAZr(p-CH~3~TPP)                 ---             ---           ---           9           ---
  (p-NO~2~TPP)                        ---             ---           ---           ---         ---
  Cl~2~Zr(p-NO~2~TPP)                 ---             ---           ---           ---         ---
  SAZr(p-NO~2~TPP)                    ---             ---           ---           ---         ---
  5-SSAZr(p-NO~2~TPP)                 10              11            15            13          11
                                                                                              
  Control chloramphenicol (10 *µ*g)   16              12            18            14          9

[^1]: Academic Editor: Konstantinos Tsipis
